oral birth control and semaglutide (Ozempic, Wegovy) control: What to know FDA-Approved Oral Semaglutide Pill |

In some cases, people may experience severe adverse health conditions, including allergic reactions, vision changes, and pancreatitis

While safety within the phase 3 program is sufficient for marketing authorization (although the risk of cardiovascular events should not exceed a hazard ratio of 1.8 according to a guidance document that was released by the FDA at that time), it is the post-marketing phase in which rare adverse events and any other potential safety risks are identified or resolved

Further research is needed to fully understand this connection

Read the concentration printed on your vial before every single injection